Showing results (31-40 of 413) with videos related to
Sort By:
Pageof 42
The Urologic Clinics of North America|May 5, 2004
The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditionsJavier Hernandez, Joseph W Basler, Ian M ThompsonUrologic Oncology|June 18, 2003
Management of high-risk localized prostate cancer: the integration of local and systemic therapy approachesSamira Syed, Daniel P Petrylak, Ian M ThompsonUrologic Oncology|April 10, 2003
Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomesJeffrey A Leslie, Tom Prihoda, Ian M ThompsonThe Journal of Urology|January 10, 2004
Prostate cancer chemoprevention: an overview of United States trialsAlbaha Barqawi, Ian M Thompson, E David CrawfordClinical Interventions in Aging|December 1, 2007
Role of 5 alpha-reductase inhibitors in the management of prostate cancerSteven J Hudak, Javier Hernandez, Ian M ThompsonCancer|May 16, 2006
Treatment options in lymph node-positive prostate cancerGregory P Swanson, Ian M Thompson, Joseph BaslerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Prevention of hormone-related cancers: prostate cancerHoward L Parnes, Ian M Thompson, Leslie G FordFoot & Ankle International|September 22, 2005
Fusion rate of first tarsometatarsal arthrodesis in the modified Lapidus procedure and flatfoot reconstructionIan M Thompson, Donald R Bohay, John G AndersonCurrent Urology Reports|April 27, 2007
Testosterone replacement therapy and prostate cancer: a word of cautionTimothy C Brand, Edith Canby-Hagino, Ian M ThompsonCA: a Cancer Journal for Clinicians|July 1, 2009
Screening for prostate cancerOtis W Brawley, Donna P Ankerst, Ian M ThompsonPageof 42